Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 408Rectal Neoplasms 152Colonic Neoplasms 150Pancreatic Neoplasms 114Stomach Neoplasms 110Neoplasm Metastasis 88Neoplasms 74Esophageal Neoplasms 60Small Cell Lung Carcinoma 45Neuroblastoma 42Lung Neoplasms 42Glioblastoma 38Carcinoma, Non-Small-Cell Lung 38Esophageal Squamous Cell Carcinoma 33Brain Neoplasms 33Unspecified Adult Solid Tumor, Protocol Specific 31Glioma 31Breast Neoplasms 28Central Nervous System Neoplasms 27Adenocarcinoma Of Esophagus 27Sarcoma 26Gliosarcoma 22Astrocytoma 22Rhabdomyosarcoma 21Sarcoma, Ewing 18Adenocarcinoma 18Gastrointestinal Neoplasms 17Oligodendroglioma 16Recurrence 14Cholangiocarcinoma 14

Interventions

Temozolomide 2Lenalidomide 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Cyclophosphamide 2venetoclax 1trametinib 1toripalimab 1tafasitamab 1sonidegib 1ribociclib 1fludarabine 1etoposide phosphate 1camrelizumab 1brivanib 1axatilimab 1apatinib 1acalabrutinib 1Vincristine 1Valganciclovir 1Thiotepa 1Therapeutics 1Telemedicine 1Tamoxifen 1Surveys and Questionnaires 1Standard of Care 1Rituximab 1Radiotherapy 1R-CHOP protocol 1Patient Navigation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pyloric Stenosis, Hypertrophic × Irinotecan × Clear all
NCT01046864 2014-09-16

Combination of Brivanib With 5-Fluorouracil/Leucovorin (5FU/LV) and 5-Fluorouracil/Leucovorin/Irinotecan (FOLFIRI)

Bristol-Myers Squibb

Phase 1 Completed
49 enrolled

Pyloric Stenosis, Hypertrophic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡